NHLRC3, a member of the miR-93-5p/17-5p/NHLRC3 axis, is also implicated in the progression of colon cancer, and it has even been reported to be an independent prognostic marker for colorectal cancer and a possible target for cancer therapy (Chen et al., 2017; Yang et al., 2022). Here, NHLRC3 is linked to malignant colon neoplasm.